Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPAREL for Postsurgical Pain in Rotator Cuff Surgery
NCT03290196Phase 4Terminated
- Sponsor
- Andrews Research & Education Foundation
- Start
- Sep 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bupivacaine in Persistent postsurgical pain (PPSP), sponsored by Andrews Research & Education Foundation. Primary endpoints: Visual Analog Scale Pain Score at 48 hours and Narcotic Medication Usage at 14 days. Started Sep 2015; status: terminated.
02
Drugs
bupivacaine
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on NCT03290196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03290196.